By JEFFREY GOLDFARB
In its pursuit of the maker of Botox, Valeant Pharmaceuticals has more work to do to reclaim the role of aggressor, writes Jeffrey Goldfarb of Reuters Breakingviews.
Published: May 28, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1kobAQR
via IFTTT
from WordPress http://ift.tt/1hesstV
No comments:
Post a Comment